Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution 3.0 Unported Licence
Correction: Therapeutic potential of a synthetic FABP4 inhibitor 8g on atherosclerosis in ApoE-deficient mice: the inhibition of lipid accumulation and inflammation
Heying Peia,
Caifeng Xieb,
Yibin Liua,
Mingfeng Shaoa,
Jinying Chena,
Dan Lia,
Liang Mac and
Lijuan Chen*a
aState Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Keyuan Road 4, Gaopeng Street, Chengdu, 610041, China. E-mail: chenlijuan125@163.com; Fax: +86-28-85164060; Tel: +86-28-85164063
bInstitute of Translational Medicine, Nanchang University, Nanchang, Jiangxi 330031, P. R. China
cDivision of Nephrology, Kidney Research Institute, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, China
First published on 7th February 2017
Abstract
Correction for ‘Therapeutic potential of a synthetic FABP4 inhibitor 8g on atherosclerosis in ApoE-deficient mice: the inhibition of lipid accumulation and inflammation’ by Heying Pei et al., RSC Adv., 2016, 6, 52518–52527.
The authors regret that funding details were omitted from the Acknowledgements section of the original article. An acknowledgement of further NSFC funding (ID: 81373260) should be included.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
| This journal is © The Royal Society of Chemistry 2017 |